Phase Ia/Ib Study of RS-0139 in Patients With a Recurrent, Locally Advanced or Metastatic NSCLC
Condition(s):NSCLCLast Updated:November 22, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):NSCLCLast Updated:November 22, 2023Recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:March 22, 2022Recruiting
Condition(s):Advanced Non-small Cell Lung Cancer With KRAS G12C MutationLast Updated:August 9, 2023Recruiting
Condition(s):NSCLCLast Updated:May 3, 2021Not yet recruiting
Condition(s):Advanced or Metastatic NSCLCLast Updated:June 28, 2022Recruiting
Condition(s):NSCLC; NSCLC Stage IV; NSCLC, RecurrentLast Updated:January 27, 2023Recruiting
Condition(s):ALK-positive NSCLCLast Updated:August 1, 2022Not yet recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:March 19, 2024Recruiting
Condition(s):Lung Cancer; Non Small Cell Lung CancerLast Updated:March 12, 2024Recruiting
Condition(s):Unresectable /Inoperable Locally Advanced (Stage II-III) Non-small Cells Lung Cancer (NSCLC)Last Updated:February 28, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.